These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33007039)

  • 1. Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
    Zuchelkowski BE; Wang L; Gingras S; Xu Q; Yang M; Triulzi D; Page GP; Gordeuk VR; Kim-Shapiro DB; Lee JS; Gladwin MT
    PLoS One; 2020; 15(10):e0240266. PubMed ID: 33007039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
    Ramirez de Oleo IE; Mejia Saldarriaga M; Johnson BK
    J Clin Rheumatol; 2022 Jan; 28(1):e23-e25. PubMed ID: 32956151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
    Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
    Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
    Beauverd Y; Adam Y; Assouline B; Samii K
    Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
    Maillart E; Leemans S; Van Noten H; Vandergraesen T; Mahadeb B; Salaouatchi MT; De Bels D; Clevenbergh P
    Infect Dis (Lond); 2020 Sep; 52(9):659-661. PubMed ID: 32496938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
    Aguilar J; Averbukh Y
    Perm J; 2020; 24():. PubMed ID: 33183501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.
    Mohammad S; Clowse MEB; Eudy AM; Criscione-Schreiber LG
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):481-485. PubMed ID: 28556555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
    Chaney S; Basirat A; McDermott R; Keenan N; Moloney E
    QJM; 2020 Dec; 113(12):890-891. PubMed ID: 32936918
    [No Abstract]   [Full Text] [Related]  

  • 10. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of an African glucose-6-phosphate dehydrogenase (G6PD) polymorphism (Val68Met) on red blood cell hemolytic propensity and post-transfusion recovery.
    Wang L; Rochon ER; Gingras S; Zuchelkowski BE; Sinchar DJ; Alipour E; Reisz JA; Yang M; Page GP; Kanias T; Triulzi DJ; Lee JS; Kim-Shapiro DB; D'Alessandro A; Gladwin MT
    Transfusion; 2024 Apr; 64(4):615-626. PubMed ID: 38400625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
    Sasi S; Yassin MA; Nair AP; Al Maslamani MS
    Am J Case Rep; 2020 Jul; 21():e925788. PubMed ID: 32697769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19.
    Cui C; Tu S; En VSJ; Li X; Yao X; Li H; Liu D
    Curr Drug Metab; 2020; 21(6):427-435. PubMed ID: 32520683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.
    Infante M; Ricordi C; Fabbri A
    J Diabetes; 2020 Sep; 12(9):659-667. PubMed ID: 32401405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
    Dar SA; Wahid M; Haque S; Almalki SS; Akhter N
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7923-7924. PubMed ID: 32767316
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
    Satlin MJ; Goyal P; Magleby R; Maldarelli GA; Pham K; Kondo M; Schenck EJ; Rennert H; Westblade LF; Choi JJ; Safford MM; Gulick RM
    PLoS One; 2020; 15(7):e0236778. PubMed ID: 32701969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
    Afra TP; Nampoothiri RV; Razmi T M; Hafi NAB
    Eur J Intern Med; 2020 Oct; 80():101-102. PubMed ID: 32651040
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
    Ibrahim H; Perl A; Smith D; Lewis T; Kon Z; Goldenberg R; Yarta K; Staniloae C; Williams M
    Clin Immunol; 2020 Oct; 219():108544. PubMed ID: 32707089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
    Oymak Y; Karapinar TH; Devrim İ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):35-36. PubMed ID: 32496442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.